Comment from Parexel International

Summary: The commenter provides extensive technical feedback and specific recommendations for revising the SUPAC Guidance documents. They suggest aligning the guidance with ICH standards, harmonizing dissolution testing criteria, and streamlining redundant sections between different dosage form GUIs.